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Job strain and COPD exacerbations: an
individual-participant meta-analysis
To the Editor:
Chronic obstructive pulmonary disease (COPD) is a major cause of mortality and disability worldwide [1].
The clinical course of COPD is characterised by exacerbations, which can be minor and manageable at
home or in primary care, or severe, leading to hospitalisation or even death. Known causes of exacerbations
include tobacco smoke, air pollution, dusts and fumes, and respiratory infections [1, 2]. One less well
understood risk factor is stress, which could plausibly lead to COPD exacerbations as it can trigger
inflammation [3, 4] and is associated with increased smoking [5], which are both implicated in COPD
pathology [2]. Work is an important source of stress in the age groups in which COPD is typically
diagnosed [1, 6]. However, we are not aware of previous investigations of work-related stress and the risk
of COPD exacerbations.
In this study, we examined the associations between job strain (the most widely studied conceptualisation of
work-related stress) and severe COPD exacerbations using individual-level data from 10 prospective cohort
studies from the Individual Participant Data Meta-analysis in Working Populations (IPD-Work)
Consortium [7]. Job strain is defined as a combination of high demands (excessive amounts of work)
and low control (having little influence on what tasks to do and how to carry them out) at work.
We ascertained job strain from the participants’ responses to questions on demands and control aspects of
their work at study baseline. The responses were scored and for each participant, and mean scores were
calculated for job-demand items and job-control items. Based on these, participants’ job demands and job
control were defined as high or low. A combination of high demands (a job demand score above the study-
specific median) and low control (job control score below the study-specific median) was defined as high
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strain and all other combinations as no strain. Job strain was validated and harmonised across the studies
[7] and modelled as a binary exposure (high strain versus no strain).
Severe COPD exacerbations were ascertained from national hospitalisation and death registers and defined
as International Classification of Diseases version 9 codes 491, 492 and 496, or version 10 codes J41, J42, J43
and J44. Our analyses were adjusted for harmonised age, sex, socioeconomic position, body mass index
(BMI), tobacco smoking and alcohol intake.
We modelled the study-specific associations between job strain and COPD exacerbations using Cox
regression. The Schoenfeld test suggested the proportional hazards assumption to be valid. Study-specific
estimates were pooled in random effects meta-analyses and heterogeneity among these quantified using the
I2-statistic. All statistical analyses were conducted using Stata 11 (Stata Corporation Ltd, College Station,
TX, USA), apart from study-specific analyses in the Danish studies, which were conducted using SAS 9.2
(SAS Institute Inc., Cary, NC, USA).
Our analyses were based on 92 428 males and females (median age at baseline: 42 years), of whom 451
experienced a COPD exacerbation leading to hospitalisation (n5431) or death (n520) during the follow-up
(table 1). The median length of follow-up was 10 years, ranging from 2 to 23 years, and the mean¡SD age at
first severe COPD exacerbation was 60¡9 years. Participants with job strain at baseline had a 32% higher risk
of a severe COPD exacerbation (hazard ratio (HR) 1.32, 95% CI 1.04–1.68) than those with no strain in the
age and sex-adjusted analyses (table 1). However, with additional adjustment for BMI, alcohol intake, smoking
and socioeconomic position, this association attenuated to the null (HR 1.10, 95% CI 0.86–1.41).
When we stratified our analyses by baseline smoking status, there was no robust evidence for an association
between job strain and the risk of COPD exacerbations among baseline smokers or baseline never-smokers
after adjustment for potential confounders. Among baseline ex-smokers, job strain (compared with no
strain) was associated with a 2.11-fold risk of a severe exacerbation (95% CI 1.03–4.31), independently of
age, sex, socioeconomic position, BMI and alcohol intake (24 539 ex-smokers, including 63 cases of severe
COPD exacerbation, 15 among participants with and 48 among those without job strain). All findings were
similar in the analyses with the job strain model quadrants (passive job, active job and high strain compared
with low strain) as the exposure as well as in sensitivity analyses with all asthma cases excluded.
In our meta-analyses, job strain was not associated with the risk of severe COPD exacerbations,
independently of age, sex, socioeconomic position, BMI, smoking and alcohol intake. We found no
association between job strain and severe COPD exacerbations among baseline never-smokers or baseline
smokers but, among baseline ex-smokers, job strain was associated with an approximately two-fold
increased risk of a severe exacerbation. The last finding should be interpreted as hypothesis generating, as it
was based on small numbers and could be a chance finding. Baseline ex-smokers with COPD may have a
more advanced disease than the COPD cases in the other smoking categories and our findings may also
reflect the high risk of exacerbation at advanced stages of COPD (with the disease process causing both
stress and exacerbations).
An important strength of our meta-analysis was that we used a large set of prospectively collected
individual-level data. Of the 10 studies, five were population-based and another five were workplace-based
but included participants from across the socioeconomic range (table 1). Thus, our findings are likely
generalisable to the northern European workforce. We used a validated and harmonised exposure, job strain
[7], and register-based COPD outcomes, which have good coverage and which are generally not prone to
recall or other biases [8–10]. In addition to in-patient data, the hospitalisation registers covered outpatient
appointments onwards from the mid-1990s in the Finnish and Danish studies [11] and from 2003 in the
UK study [12].
It is a limitation of our study that a single baseline measurement of job strain may have been too imprecise
an indicator of the exposure, which may have diluted our association estimates. Further research with
repeated measurements of job strain over time would clarify this issue. Another limitation is that we had no
data on disease severity or lung function at baseline. Other unmeasured confounders that might have
influenced our estimates and should be controlled for in future studies include occupational exposures,
concurrent illnesses, social support and physical activity. Finally, as our outcomes were severe COPD
exacerbations, our findings are not necessarily generalisable to mild exacerbations.
We adjusted our analyses for smoking and alcohol intake but these could plausibly be on the causal pathway
between job strain and COPD exacerbations. However, previous analyses of the IPD-Work Consortium
data provided no conclusive evidence for longitudinal associations of job strain with smoking or alcohol
intake, though job strain was associated with increasing smoking intensity. Further research would help to
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understand the direction of these associations, for if smoking and alcohol were mediators, job strain might
be associated with COPD exacerbations via these risk factors.
In conclusion, our meta-analyses suggest that job strain is not associated with severe COPD exacerbations,
though imprecise exposure or residual confounding may have influenced our results. This investigation
should therefore be considered a hypothesis-generating study to encourage further research in this area.
Importantly, associations between repeated measurements of job strain and indicators of COPD severity
(e.g. lung function tests) would merit further study.
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HIV and multidrug-resistant tuberculosis:
overlapping epidemics
To the Editor:
People infected with Mycobacterium tuberculosis and HIV are much more likely to develop active
tuberculosis (TB) than people with M. tuberculosis but without HIV [1]. Patients infected with multidrug-
resistant (MDR)-TB (defined as resistance to at least rifampicin and isoniazid, the two most powerful anti-
TB drugs) require longer, more expensive treatment regimens than drug-susceptible TB, with poorer
treatment success [2, 3]. Therefore, MDR-TB poses a major challenge to the control of TB, with an
estimated global disease incidence in 2012 of ,450 000 cases (95% CI 300 000–600 000) [4]. Although HIV
is a powerful risk factor for all forms of TB and institutional outbreaks of MDR-TB among people living
with HIV have been reported [5], population-level data on the association between HIV infection and
MDR-TB are limited.
We explored the relationship between HIV infection and MDR-TB disease using data reported by member
states to the World Health Organization (WHO) within the context of the Global Project on Anti-TB Drug
Resistance Surveillance. The data were aggregated numbers of cases reported from either drug resistance
surveys or continuous surveillance systems. Such surveys are epidemiological studies designed to measure
drug resistance among a representative sample of notified pulmonary TB patients. Continuous surveillance
is based on routine drug susceptibility testing of all bacteriologically confirmed TB patients. Subnational
level data that were not representative of the entire country were excluded from the analysis, except for the
Russian Federation and Ukraine, which are high MDR-TB burden countries for which high quality national
level data were not available. The data included in the analysis met the criteria for data quality and national
representativeness provided in detail elsewhere [4, 6]. The laboratory methods used for diagnosis were
endorsed by WHO.
For each country, the relationship between HIV infection and MDR-TB disease was investigated by logistic
regression to calculate odds ratios and 95% confidence intervals, using Stata (version 12; StataCorp, College
Station, TX, USA). For countries with data from multiple years, robust standard errors accounted for
within-country time dependencies. In order to minimise bias, data for a given year were excluded if f25%
of reported TB patients had a documented HIV test result. 41 countries, accounting for 25% of the
estimated global MDR-TB burden in 2012, met the inclusion criteria for o1 year. Most were high-income
countries and/or in the European Region. Only four countries were in the African region, which accounted
for 75% of the global number of HIV-positive TB cases in 2012 [4]. Of these 41 countries, odds ratios could
be calculated for 24 countries; the other 17 countries reported no HIV-positive MDR-TB cases (table 1).
Complete HIV and MDR-TB data were available for 104 781 TB patients from 1997–2012.
For 11 of the 24 countries for which the analysis was performed, HIV-positive TB patients had a
significantly higher odds (p,0.05) of MDR-TB disease than HIV-negative TB patients (table 1). Seven of
these countries were in eastern Europe and central Asia: Estonia, Kazakhstan, Latvia, the Republic of
Moldova, the Russian Federation, the Ukraine and Uzbekistan. For almost all of these 11 countries, the
prevalence of MDR-TB among newly diagnosed TB cases (table 1) was higher than the estimated global
average of 3.6% (95% CI 2.1–5.1%) in 2012 [4]. Although the odds ratio was highest in Kuwait, only low
numbers of HIV-positive cases were reported. HIV-positive TB patients in the USA had a lower odds of
MDR-TB disease than HIV-negative patients.
As data were included if o75% of reported TB patients had a documented HIV test, the possibility of bias
due to missing data cannot be ruled out. Although a positive association between HIV infection and MDR-
TB disease was demonstrated in less than half of the countries, a recent systematic review and meta-analysis
found an odds of MDR-TB in HIV-positive patients that was 1.24 times (95% CI 1.04–1.43) higher than in
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